{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:52:31Z","timestamp":1781650351919,"version":"3.54.5"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002352","name":"Ain Shams University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Acute kidney injury (AKI) represents a critical complication in patients with acute coronary syndrome (ACS), particularly in patients undergoing percutaneous coronary intervention (PCI). Current tests for detecting early AKI, such as creatinine and cystatin C, have modest sensitivity. This study explores the role of bioinformatics in creating an implementable predictive key gene in cardiorenal pathogenesis and evaluates the diagnostic potential of\n                      <jats:italic>GTF2I<\/jats:italic>\n                      ,\n                      <jats:italic>ANGPTL4<\/jats:italic>\n                      , and\n                      <jats:italic>MMP14<\/jats:italic>\n                      in predicting AKI in ACS patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This is a single-center prospective observational cohort study that enrolled 167 participants: healthy controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200960), ACS patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200956), and ACS patients with AKI (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200951). Baseline clinical and renal markers were measured 24\u00a0h pre-PCI, with RNA biomarkers (\n                      <jats:italic>GTF2I<\/jats:italic>\n                      ,\n                      <jats:italic>ANGPTL4<\/jats:italic>\n                      ,\n                      <jats:italic>MMP14<\/jats:italic>\n                      ) assessed at 48\u00a0h post-PCI, with daily creatinine monitoring performed for up to 6 days after PCI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>GTF2I<\/jats:italic>\n                      ,\n                      <jats:italic>ANGPTL4<\/jats:italic>\n                      , and\n                      <jats:italic>MMP14<\/jats:italic>\n                      were significantly elevated in ACS patients, with further increases in ACS-AKI patients.\n                      <jats:italic>GTF2I<\/jats:italic>\n                      showed the strongest predictive accuracy for AKI (AUC\u2009=\u20090.98), outperforming creatinine and cystatin.\n                      <jats:italic>ANGPTL4<\/jats:italic>\n                      correlated negatively with serum creatinine (\n                      <jats:italic>r<\/jats:italic>\n                      = \u2212\u20090.213,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006), suggesting a modulatory role in renal injury, while\n                      <jats:italic>MMP14<\/jats:italic>\n                      elevations were pronounced in ACS-AKI. Notably, the combined biomarker panel achieved the highest diagnostic accuracy (AUC\u2009=\u20090.99), underscoring its potential as a robust early predictor of AKI. Subgroup analysis in diabetic patients revealed differential biomarker expression between AKI and non-AKI cases. Logistic regression confirmed albuminuria,\n                      <jats:italic>ANGPTL4<\/jats:italic>\n                      ,\n                      <jats:italic>GTF2I<\/jats:italic>\n                      , and\n                      <jats:italic>MMP14<\/jats:italic>\n                      , in addition to several metabolic biomarkers, as significant predictors of AKI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>GTF2I<\/jats:italic>\n                      ,\n                      <jats:italic>ANGPTL4<\/jats:italic>\n                      , and\n                      <jats:italic>MMP14<\/jats:italic>\n                      are promising biomarkers for predicting AKI in ACS patients and could be integrated into clinical practice for early AKI detection, improving patient management and outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-04926-w","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T04:12:56Z","timestamp":1776139976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNA biomarker signatures for prediction of acute kidney injury in acute coronary syndrome patients undergoing PCI"],"prefix":"10.1186","volume":"27","author":[{"given":"Radwa","family":"Khaled","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"El-Zayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Ragheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Elsayed","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Matboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"4926_CR1","doi-asserted-by":"crossref","unstructured":"Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022;399.","DOI":"10.1016\/S0140-6736(21)02391-6"},{"key":"4926_CR2","doi-asserted-by":"crossref","unstructured":"Timmis A, Kazakiewicz D, Townsend N, Huculeci R, Aboyans V, Vardas P. Global epidemiology of acute coronary syndromes. Nat Rev Cardiol. 2023;20.","DOI":"10.1038\/s41569-023-00884-0"},{"key":"4926_CR3","doi-asserted-by":"crossref","unstructured":"Lindahl B. Acute coronary syndrome - The present and future role of biomarkers1. Clin Chem Lab Med. 2013;51.","DOI":"10.1515\/cclm-2013-0074"},{"key":"4926_CR4","doi-asserted-by":"crossref","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, J\u00fcni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Gimenez MR, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B, Halvorsen S, James S, Abdelhamid M, Aboyans V, Marsan NA, Antoniou S, Asteggiano R, B\u00e4ck M, Capodanno D, Casado-Arroyo R, Cassese S, \u010celutkiene J, Cikes M, Collet JP, Ducrocq G, Falk V, Fauchier L, Geisler T, Gorog DA, Holmvang L, Jaarsma T, Jones HW, K\u00f8ber L, Koskinas KC, Kotecha D, Krychtiuk KA, Landmesser U, Lazaros G, Lewis BS, Lindahl B, Linhart A, L\u00f8chen ML, Mamas MA, McEvoy JW, Mihaylova B, Mindham R, Mueller C, Neubeck L, Niebauer J, Nielsen JC, Niessner A, Paradies V, Pasquet AA, Petersen SE, Prescott E, Rakisheva A, Rocca B, Rosano GMC, Sade LE, Schiele F, Siller-Matula JM, Sticherling C, Storey RF, Thielmann M, Vrints C, Windecker S, Wiseth R, Witkowski A. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Hear J Acute Cardiovasc Care. 2024;13.","DOI":"10.1093\/ehjacc\/zuad107"},{"key":"4926_CR5","doi-asserted-by":"publisher","unstructured":"Wang JN, Wang F, Ke J, Li Z, Xu CH, Yang Q, Chen X, He XY, He Y, Suo XG, Li C, Yu JT, Jiang L, Ni WJ, Jin J, Liu MM, Shao W, Yang C, Gong Q, Chen HY, Li J, Wu YG, Meng XM. Inhibition of METTL3 attenuates renal injury and inflammation by alleviating Table 3 m6A modifications via IGF2BP2-dependent mechanisms. Sci Transl Med. 2022;14. https:\/\/doi.org\/10.1126\/scitranslmed.abk2709.","DOI":"10.1126\/scitranslmed.abk2709"},{"key":"4926_CR6","doi-asserted-by":"publisher","unstructured":"De Santo LS, Romano G, Amarelli C, Maiello C, Baldascino F, Bancone C, Grimaldi F, Nappi G. Implications of acute kidney injury after heart transplantation: What a surgeon should know. Eur J Cardio-thoracic Surg. 2011;40. https:\/\/doi.org\/10.1016\/j.ejcts.2011.02.068.","DOI":"10.1016\/j.ejcts.2011.02.068"},{"key":"4926_CR7","doi-asserted-by":"crossref","unstructured":"Cruz DN. Cardiorenal syndrome in critical care: the acute cardiorenal and renocardiac syndromes. Adv Chronic Kidney Dis. 2013;20.","DOI":"10.1053\/j.ackd.2012.10.005"},{"key":"4926_CR8","doi-asserted-by":"publisher","unstructured":"Washam JB, Herzog CA, Beitelshees AL, Cohen MG, Henry TD, Kapur NK, Mega JL, Menon V, Page RL, Newby LK. Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome: A scientific statement from the American Heart Association. Circulation. 2015;131. https:\/\/doi.org\/10.1161\/CIR.0000000000000183.","DOI":"10.1161\/CIR.0000000000000183"},{"key":"4926_CR9","doi-asserted-by":"crossref","unstructured":"Fan PC, Chang CH, Chen YC. Biomarkers for acute cardiorenal syndrome. Nephrology. 2018;23.","DOI":"10.1111\/nep.13473"},{"key":"4926_CR10","doi-asserted-by":"crossref","unstructured":"Lewington AJP, Cerd\u00e1 J, Mehta RL. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int. 2013;84.","DOI":"10.1038\/ki.2013.153"},{"key":"4926_CR11","doi-asserted-by":"publisher","unstructured":"Priyanka P, Zarbock A, Izawa J, Gleason TG, Renfurm RW, Kellum JA. The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients. J Thorac Cardiovasc Surg. 2021;162. https:\/\/doi.org\/10.1016\/j.jtcvs.2019.11.137.","DOI":"10.1016\/j.jtcvs.2019.11.137"},{"key":"4926_CR12","doi-asserted-by":"publisher","unstructured":"Zhunuspekova A, Mansurova J, Karazhanova L. Independent predictors of acute kidney injury in patients with acute coronary syndrome after percutaneous coronary intervention. PLoS ONE. 2021;16. https:\/\/doi.org\/10.1371\/journal.pone.0247304.","DOI":"10.1371\/journal.pone.0247304"},{"key":"4926_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/00033197231185445","author":"Z Yang","year":"2023","unstructured":"Yang Z, Qiao Y, Wang D, Yan G, Tang C. Association Between Inflammatory Biomarkers and Contrast-induced Acute Kidney Injury in ACS Patients Undergoing Percutaneous Coronary Intervention: A Cross-sectional Study. Angiology. 2023. https:\/\/doi.org\/10.1177\/00033197231185445.","journal-title":"Angiology"},{"key":"4926_CR14","doi-asserted-by":"crossref","unstructured":"Auer J, Verbrugge FH, Lamm G, editors. Editor\u2019s Choice- What do small serum creatinine changes tell us about outcomes after acute myocardial infarction? Eur. Hear. J. Acute Cardiovasc; 2018. Care 7.","DOI":"10.1177\/2048872617728721"},{"key":"4926_CR15","doi-asserted-by":"publisher","unstructured":"Zhang Z, Lu B, Sheng X, Jin N. Cystatin C in prediction of acute kidney injury: A systemic review and meta-analysis. Am J Kidney Dis. 2011;58. https:\/\/doi.org\/10.1053\/j.ajkd.2011.02.389.","DOI":"10.1053\/j.ajkd.2011.02.389"},{"key":"4926_CR16","doi-asserted-by":"publisher","unstructured":"Rimes-Stigare C, Ravn B, Awad A, Torl\u00e9n K, Martling CR, Bottai M, M\u00e5rtensson J, Bell M. Creatinine- and cystatin C-based incidence of chronic kidney disease and acute kidney disease in aki survivors. Crit Care Res Pract. 2018;2018. https:\/\/doi.org\/10.1155\/2018\/7698090.","DOI":"10.1155\/2018\/7698090"},{"key":"4926_CR17","doi-asserted-by":"publisher","unstructured":"Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, Safford MM, Zhang X, Muntner P, Warnock D. Detection of chronic kidney disease with creatinine, cystatin c, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011;305. https:\/\/doi.org\/10.1001\/jama.2011.468.","DOI":"10.1001\/jama.2011.468"},{"key":"4926_CR18","doi-asserted-by":"crossref","unstructured":"Gaut JP, Liapis H. Acute kidney injury pathology and pathophysiology: a retrospective review. Clin Kidney J. 2021;14.","DOI":"10.1093\/ckj\/sfaa142"},{"key":"4926_CR19","doi-asserted-by":"crossref","unstructured":"Erpicum P, Hanssen O, Weekers L, Lovinfosse P, Meunier P, Tshibanda L, Krzesinski JM, Hustinx R, Jouret F. Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: Omics analyses of urine and blood samples. Clin Kidney J. 2017;10.","DOI":"10.1093\/ckj\/sfw077"},{"key":"4926_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2016.09.014","author":"H Chen","year":"2016","unstructured":"Chen H, Cao G, Chen DQ, Wang M, Vaziri ND, Zhang ZH, Mao JR, Bai X, Zhao YY. Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression. Redox Biol. 2016;10. https:\/\/doi.org\/10.1016\/j.redox.2016.09.014.","journal-title":"Redox Biol"},{"key":"4926_CR21","doi-asserted-by":"crossref","unstructured":"Zhao L, Hao Y, Tang S, Han X, Li R, Zhou X. Energy metabolic reprogramming regulates programmed cell death of renal tubular epithelial cells and might serve as a new therapeutic target for acute kidney injury. Front Cell Dev Biol. 2023;11.","DOI":"10.3389\/fcell.2023.1276217"},{"key":"4926_CR22","doi-asserted-by":"crossref","unstructured":"Zhang X, Li X. Abnormal iron and lipid metabolism mediated ferroptosis in kidney diseases and its therapeutic potential. Metabolites. 2022;12.","DOI":"10.3390\/metabo12010058"},{"key":"4926_CR23","doi-asserted-by":"crossref","unstructured":"Bouchard J, Mehta RL. Angiogenesis markers and recovery from acute kidney injury: a piece of the puzzle? Am J Kidney Dis. 2019;74.","DOI":"10.1053\/j.ajkd.2019.03.421"},{"key":"4926_CR24","doi-asserted-by":"publisher","unstructured":"Mansour SG, Zhang WR, Moledina DG, Coca SG, Jia Y, Thiessen-Philbrook H, McArthur E, Inoue K, Koyner JL, Shlipak MG, Wilson FP, Garg AX, Ishibe S, Parikh CR. The association of angiogenesis markers with acute kidney injury and mortality after cardiac surgery. Am J Kidney Dis. 2019;74. https:\/\/doi.org\/10.1053\/j.ajkd.2019.01.028.","DOI":"10.1053\/j.ajkd.2019.01.028"},{"key":"4926_CR25","doi-asserted-by":"crossref","unstructured":"Roy AL. Pathophysiology of TFII-I: old guard wearing new hats. Trends Mol Med. 2017;23.","DOI":"10.1016\/j.molmed.2017.04.002"},{"key":"4926_CR26","doi-asserted-by":"publisher","unstructured":"Meng Y, He Y, Zhang J, Xie Q, Yang M, Chen Y, Wu Y. Association of GTF2I gene polymorphisms with renal involvement of systemic lupus erythematosus in a Chinese population. Med (United States). 2019;98. https:\/\/doi.org\/10.1097\/MD.0000000000016716.","DOI":"10.1097\/MD.0000000000016716"},{"key":"4926_CR27","doi-asserted-by":"crossref","unstructured":"Zuo Y, He Z, Chen Y, Dai L. Dual role of ANGPTL4 in inflammation. Inflamm Res. 2023;72.","DOI":"10.1007\/s00011-023-01753-9"},{"key":"4926_CR28","doi-asserted-by":"publisher","unstructured":"Aarset\u00f8y R, Ueland T, Aukrust P, Michelsen AE, de la Fuente RL, P\u00f6nitz V, Br\u00fcgger-Andersen T, Grundt H, Staines H, Nilsen DWT. Angiopoietin-2 and angiopoietin-like 4 protein provide prognostic information in patients with suspected acute coronary syndrome. J Intern Med. 2021;290. https:\/\/doi.org\/10.1111\/joim.13339.","DOI":"10.1111\/joim.13339"},{"key":"4926_CR29","doi-asserted-by":"crossref","unstructured":"Goenka L, George M, Singh V, Jena A, Seshadri D, Karunakaran V, Elumalai DV, Rani J, Kaliappan I. Do ANGPTL-4 and galectin-3 reflect the severity of coronary artery disease? Ther Adv Cardiovasc Dis. 2017;11.","DOI":"10.1177\/1753944717723311"},{"key":"4926_CR30","doi-asserted-by":"publisher","unstructured":"Baranowski T, Kralisch S, Bachmann A, L\u00f6ssner U, Kratzsch J, Bl\u00fcher M, Stumvoll M, Fasshauer M. Serum levels of the adipokine fasting-induced adipose factor\/angiopoietin- like protein 4 depend on renal function. Horm Metab Res. 2011;43. https:\/\/doi.org\/10.1055\/s-0030-1267917.","DOI":"10.1055\/s-0030-1267917"},{"key":"4926_CR31","doi-asserted-by":"publisher","unstructured":"Provenzano M, Andreucci M, Garofalo C, Faga T, Michael A, Ielapi N, Grande R, Sapienza P, de Franciscis S, Mastroroberto P, Serra R. The association of matrix metalloproteinases with chronic kidney disease and peripheral vascular disease: A light at the end of the tunnel? Biomolecules. 2020;10. https:\/\/doi.org\/10.3390\/biom10010154.","DOI":"10.3390\/biom10010154"},{"key":"4926_CR32","doi-asserted-by":"publisher","unstructured":"Gallardo-Vara E, Blanco FJ, Roqu\u00e9 M, Friedman SL, Suzuki T, Botella LM, Bernabeu C. Transcription factor KLF6 upregulates expression of metalloprotease MMP14 and subsequent release of soluble endoglin during vascular injury. Angiogenesis. 2016;19. https:\/\/doi.org\/10.1007\/s10456-016-9495-8.","DOI":"10.1007\/s10456-016-9495-8"},{"key":"4926_CR33","doi-asserted-by":"publisher","unstructured":"Petra E, He T, Lygirou V, Latosinska A, Mischak H, Vlahou A, Jankowski J. Urine peptidome analysis in cardiorenal syndrome reflects molecular processes. Sci Rep. 2021;11. https:\/\/doi.org\/10.1038\/s41598-021-95695-z.","DOI":"10.1038\/s41598-021-95695-z"},{"key":"4926_CR34","doi-asserted-by":"publisher","unstructured":"Liang J, Lin G, Tian J, Chen J, Liang R, Chen Z, Deng Q, Dong Z, Liu T, Wu Y. Measurement of urinary matrix metalloproteinase-7 for early diagnosis of acute kidney injury based on an ultrasensitive immunomagnetic microparticle-based time-resolved fluoroimmunoassay. Clin Chim Acta. 2019;490. https:\/\/doi.org\/10.1016\/j.cca.2018.11.037.","DOI":"10.1016\/j.cca.2018.11.037"},{"key":"4926_CR35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1540-8183.2010.00581.x","volume":"23","author":"E Chong","year":"2010","unstructured":"Chong E, Poh KK, Liang S, Soon CY, Tan HC. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. J Interv Cardiol. 2010;23:451\u20139. https:\/\/doi.org\/10.1111\/j.1540-8183.2010.00581.x.","journal-title":"J Interv Cardiol"},{"key":"4926_CR36","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/EURHEARTJ\/EHAD191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, J\u00fcni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Gimenez MR, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720\u2013826. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAD191.","journal-title":"Eur Heart J"},{"key":"4926_CR37","unstructured":"Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, Herzog CA, Joannidis M, Kribben A, Levey AS, MacLeod AM, Mehta RL, Murray PT, Naicker S, Opal SM, Schaefer F, Schetz M, Uchino S. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;Suppl 2."},{"key":"4926_CR38","doi-asserted-by":"crossref","unstructured":"Raber I, McCarthy CP, Januzzi JL. A test in context: interpretation of high-sensitivity cardiac troponin assays in different clinical settings. J Am Coll Cardiol. 2021;77.","DOI":"10.1016\/j.jacc.2021.01.011"},{"key":"4926_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.hlc.2025.02.102","volume":"34","author":"D Brieger","year":"2025","unstructured":"Brieger D, Cullen L, Briffa T, Zaman S, Scott I, Papendick C, Bardsley K, Baumann A, Bennett AS, Clark RA, Edelman JJ, Inglis SC, Kuhn L, Livori A, Redfern J, Schneider H, Stewart J, Thomas L, Wing-Lun E, Zhang L, Ho E, Matthews S. National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025. Heart Lung Circ. 2025;34:309\u201397. https:\/\/doi.org\/10.1016\/j.hlc.2025.02.102.","journal-title":"Heart Lung Circ"},{"key":"4926_CR40","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617;CTYPE:STRING:JOURNAL","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Corbett S, Chettibi M, Hayrapetyan H, Roithinger FX, Aliyev F, Sujayeva V, Claeys MJ, Smaji\u0107 E, Kala P, Iversen KK, Hefny E, El, Marandi T, Porela P, Antov S, Gilard M, Blankenberg S, Davlouros P, Gudnason T, Alcalai R, Colivicchi F, Elezi S, Baitova G, Zakke I, Gustiene O, Beissel J, Dingli P, Grosu A, Damman P, Juliebo V, Legutko J, Morais J, Tatu-Chitoiu G, Yakovlev A, Zavatta M, Nedeljkovic M, Radsel P, Sionis A, Jemberg T, M\u00fcller C, Abid L, Abaci A, Parkhomenko A. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138:e618\u201351. https:\/\/doi.org\/10.1161\/CIR.0000000000000617;CTYPE:STRING:JOURNAL.","journal-title":"Circulation"},{"key":"4926_CR41","doi-asserted-by":"publisher","unstructured":"Delgado C, Baweja M, Burrows NR, Crews DC, Eneanya ND, Gadegbeku CA, Inker LA, Mendu ML, Miller WG, Moxey-Mims MM, Roberts GV, St., Peter WL, Warfield C, Powe NR. Reassessing the inclusion of race in diagnosing kidney diseases: an interim report from the NKF-ASN task force. Am J Kidney Dis. 2021;78:103\u2013115. https:\/\/doi.org\/10.1053\/J.AJKD.2021.03.008","DOI":"10.1053\/J.AJKD.2021.03.008"},{"key":"4926_CR42","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF, Feldman HI, Kusek JW, Eggers P, Lente F, Van, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. https:\/\/doi.org\/107326\/0003-4819-150-9-200905050-00006 2009;150:604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"4926_CR43","unstructured":"Previous eGFR Calculator for Reference - NIDDK. https:\/\/www.niddk.nih.gov\/health-information\/professionals\/clinical-tools-patient-management\/kidney-disease\/laboratory-evaluation\/estimated-gfr-calculators\/previous. Accessed 2 Jan 2026."},{"key":"4926_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u2206\u2206CT method. Methods. 2001;25:402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"key":"4926_CR45","doi-asserted-by":"publisher","unstructured":"Wang WH, Hong YC, Chen HM, Chen D, Wei KC, Lai PC. Risk Factors and Outcome of Acute Kidney Injury following Acute Myocardial Infarction\u2014A Case Series Study from 2009 to 2019. J Clin Med. 2022;11. https:\/\/doi.org\/10.3390\/jcm11206083.","DOI":"10.3390\/jcm11206083"},{"key":"4926_CR46","doi-asserted-by":"publisher","unstructured":"Tan J, Zhang YH, Si J, Xiao KL, Hua Q, Li J. Incidence, predictors and prognosis of acute kidney injury in acute ST-segment elevation myocardial infarction patients undergoing emergent coronary angiography\/primary percutaneous coronary intervention. J Geriatr Cardiol. 2023;20. https:\/\/doi.org\/10.26599\/1671-5411.2023.02.004.","DOI":"10.26599\/1671-5411.2023.02.004"},{"key":"4926_CR47","doi-asserted-by":"crossref","unstructured":"Yu Y, Li C, Zhu S, Jin L, Hu Y, Ling X, Miao C, Guo K. Diagnosis, pathophysiology and preventive strategies for cardiac surgery-associated acute kidney injury: a narrative review. Eur J Med Res. 2023;28.","DOI":"10.1186\/s40001-023-00990-2"},{"key":"4926_CR48","doi-asserted-by":"publisher","unstructured":"Lagos-Arevalo P, Palijan A, Vertullo L, Devarajan P, Bennett MR, Sabbisetti V, Bonventre JV, Ma Q, Gottesman RD, Zappitelli M. Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine? Pediatr Nephrol. 2015;30. https:\/\/doi.org\/10.1007\/s00467-014-2987-0.","DOI":"10.1007\/s00467-014-2987-0"},{"key":"4926_CR49","doi-asserted-by":"crossref","unstructured":"Rossiter A, La A, Koyner JL, Forni LG. New biomarkers in acute kidney injury. Crit Rev Clin Lab Sci. 2024;61.","DOI":"10.1080\/10408363.2023.2242481"},{"key":"4926_CR50","doi-asserted-by":"publisher","unstructured":"Tanaka S, Tanaka T, Nangaku M. (2015) Hypoxia and Dysregulated Angiogenesis in Kidney Disease. Kidney Dis 1:. https:\/\/doi.org\/10.1159\/000381515","DOI":"10.1159\/000381515"},{"key":"4926_CR51","doi-asserted-by":"publisher","unstructured":"Pallet N, Thervet E, Timsit MO. Angiogenic response following renal ischemia reperfusion injury: New players. Prog en Urol. 2014;24. https:\/\/doi.org\/10.1016\/S1166-7087(14)70059-4.","DOI":"10.1016\/S1166-7087(14)70059-4"},{"key":"4926_CR52","doi-asserted-by":"publisher","unstructured":"Ostermann M, Zarbock A, Goldstein S, Kashani K, MacEdo E, Murugan R, Bell M, Forni L, Guzzi L, Joannidis M, Kane-Gill SL, Legrand M, Mehta R, Murray PT, Pickkers P, Plebani M, Prowle J, Ricci Z, Rimmel\u00e9 T, Rosner M, Shaw AD, Kellum JA, Ronco C. Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement. JAMA Netw open. 2020;3:E2019209. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.19209","DOI":"10.1001\/jamanetworkopen.2020.19209"},{"key":"4926_CR53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","volume":"2017 134 13","author":"LS Chawla","year":"2017","unstructured":"Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, Bittleman D, Cruz D, Endre Z, Fitzgerald RL, Forni L, Kane-Gill SL, Hoste E, Koyner J, Liu KD, MacEdo E, Mehta R, Murray P, Nadim M, Ostermann M, Palevsky PM, Pannu N, Rosner M, Wald R, Zarbock A, Ronco C, Kellum JA. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;2017 134 13:241\u201357. https:\/\/doi.org\/10.1038\/nrneph.2017.2.","journal-title":"Nat Rev Nephrol"},{"key":"4926_CR54","doi-asserted-by":"publisher","first-page":"zyaf001","DOI":"10.1093\/intbio\/zyaf001","volume":"17","author":"TC Dakal","year":"2025","unstructured":"Dakal TC, Thakur M, George N, Singh TR, Yadav V, Kumar A. GTF2I acts as a novel tumor suppressor transcription factor and shows Favorable prognosis in renal cancer. Integr Biol. 2025;17:zyaf001. https:\/\/doi.org\/10.1093\/intbio\/zyaf001.","journal-title":"Integr Biol"},{"key":"4926_CR55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.14429\/dlsj.9.19455","volume":"9","author":"D Sharma","year":"2024","unstructured":"Sharma D, Kumari A, Kumari M, Varshney R, Meena RC. SUMO Sites Prediction in Human Transcription Factors Involved in Hypoxia-induced Cardiac Illnesses. Def Life Sci J. 2024;9:44\u201354. https:\/\/doi.org\/10.14429\/dlsj.9.19455.","journal-title":"Def Life Sci J"},{"key":"4926_CR56","doi-asserted-by":"publisher","unstructured":"Kim IK, Rao G, Zhao X, Fan R, Avantaggiati ML, Wang Y, Zhang YW, Giaccone G. Mutant GTF2I induces cell transformation and metabolic alterations in thymic epithelial cells. Cell Death Differ. 2020;27. https:\/\/doi.org\/10.1038\/s41418-020-0502-7.","DOI":"10.1038\/s41418-020-0502-7"},{"key":"4926_CR57","doi-asserted-by":"crossref","unstructured":"Guo L, Li SY, Ji FY, Zhao YF, Zhong Y, Lv XJ, Wu XL, Qian GS. Role of Angptl4 in vascular permeability and inflammation. Inflamm Res. 2014;63.","DOI":"10.1007\/s00011-013-0678-0"},{"key":"4926_CR58","doi-asserted-by":"crossref","unstructured":"La Paglia L, List\u00ec A, Caruso S, Amodeo V, Passiglia F, Bazan V, Fanale D. Potential role of ANGPTL4 in the cross talk between metabolism and cancer through PPAR signaling pathway. PPAR Res. 2017.","DOI":"10.1155\/2017\/8187235"},{"key":"4926_CR59","doi-asserted-by":"publisher","unstructured":"Dewey FE, Gusarova V, O\u2019Dushlaine C, Gottesman O, Trejos J, Hunt C, Van Hout CV, Habegger L, Buckler D, Lai K-MV, Leader JB, Murray MF, Ritchie MD, Kirchner HL, Ledbetter DH, Penn J, Lopez A, Borecki IB, Overton JD, Reid JG, Carey DJ, Murphy AJ, Yancopoulos GD, Baras A, Gromada J, Shuldiner AR. Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. N Engl J Med. 2016;374. https:\/\/doi.org\/10.1056\/nejmoa1510926.","DOI":"10.1056\/nejmoa1510926"},{"key":"4926_CR60","doi-asserted-by":"publisher","unstructured":"Li Ykun, Gao A bo, Zeng T, Liu D, Zhang Q, feng, Ran X min, Tang Zzi, Li Y, Liu J, Zhang T, Shi G, qing, Zhou W, chao, Zou W da, Peng J, Zhang J, Li H, Zou J. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2\/STAT3 pathway and interacting with ESM1. J Transl Med. 2024;22. https:\/\/doi.org\/10.1186\/s12967-023-04819-8","DOI":"10.1186\/s12967-023-04819-8"},{"key":"4926_CR61","doi-asserted-by":"publisher","unstructured":"Zhu X, Zhang X, Gu W, Zhao H, Hao S, Ning Z. ANGPTL4 suppresses the profibrogenic functions of atrial fibroblasts induced by angiotensin II by up-regulating PPAR\u03b3. Iran J Basic Med Sci. 2023;26. https:\/\/doi.org\/10.22038\/IJBMS.2023.69196.15077.","DOI":"10.22038\/IJBMS.2023.69196.15077"},{"key":"4926_CR62","doi-asserted-by":"publisher","unstructured":"Li Y, Xu Z, Deng H, Liu M, Lin X, Zhang M, Li G, Yue S, Gao X. ANGPTL4 promotes nephrotic syndrome by downregulating podocyte expression of ACTN4 and podocin. Biochem Biophys Res Commun. 2023;639. https:\/\/doi.org\/10.1016\/j.bbrc.2022.11.081.","DOI":"10.1016\/j.bbrc.2022.11.081"},{"key":"4926_CR63","doi-asserted-by":"publisher","unstructured":"Chen WQ, Zhang Y, Jiang H, Li H, Li XY, Yang X, Feng S, Wang YC, Linc H, Shen XJ, Zhou Q, Jin J, Chen JH. Podocyte-related proteins in membranous nephropathy progression. Chin Med J (Engl). 2013;126. https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.20131056.","DOI":"10.3760\/cma.j.issn.0366-6999.20131056"},{"key":"4926_CR64","doi-asserted-by":"publisher","unstructured":"Zhao YW, Ma W, Jiang F, Xie Y, Tang L. Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma-a bioinformatics analysis. Transl Androl Urol. 2022;11. https:\/\/doi.org\/10.21037\/tau-22-619.","DOI":"10.21037\/tau-22-619"},{"key":"4926_CR65","doi-asserted-by":"publisher","DOI":"10.2174\/1874192401105010110","author":"A Tanindi","year":"2011","unstructured":"Tanindi A. Relationship Between MMP-1, MMP-9, TIMP-1, IL-6 and Risk Factors, Clinical Presentation, Extent and Severity of Atherosclerotic Coronary Artery Disease. Open Cardiovasc Med J. 2011. https:\/\/doi.org\/10.2174\/1874192401105010110. 5:.","journal-title":"Open Cardiovasc Med J"},{"key":"4926_CR66","doi-asserted-by":"publisher","DOI":"10.14715\/CMB\/2022.68.11.16","author":"W Wang","year":"2022","unstructured":"Wang W. Correlation between Extracellular Matrix Metalloproteinase Inducer in Peripheral Blood and Serum MMPs in patients with Acute Coronary Syndrome. Cell Mol Biol. 2022. https:\/\/doi.org\/10.14715\/CMB\/2022.68.11.16. 68:.","journal-title":"Cell Mol Biol"},{"key":"4926_CR67","doi-asserted-by":"publisher","unstructured":"Liu H, Hu G, Wang Z, Liu Q, Zhang J, Chen Y, Huang Y, Xue W, Xu Y, Zhai W, Xue W, Xu Y, Zhai W. (2020) circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p\/MMP14 axis. Theranostics 10:. https:\/\/doi.org\/10.7150\/thno.47239","DOI":"10.7150\/thno.47239"},{"key":"4926_CR68","doi-asserted-by":"publisher","unstructured":"Petra E, Siwy J, Vlahou A, Jankowski J. Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease. PLoS ONE. 2022;17. https:\/\/doi.org\/10.1371\/journal.pone.0262667.","DOI":"10.1371\/journal.pone.0262667"},{"key":"4926_CR69","doi-asserted-by":"publisher","unstructured":"Landolt L, Eikrem \u00d8, Strauss P, Scherer A, Lovett DH, Beisland C, Finne K, Osman T, Ibrahim MM, Gausdal G, Ahmed L, Lorens JB, Thiery JP, Tan TZ, Sekulic M, Marti HP. Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis. Physiol Rep. 2017;5. https:\/\/doi.org\/10.14814\/phy2.13305.","DOI":"10.14814\/phy2.13305"},{"key":"4926_CR70","doi-asserted-by":"publisher","unstructured":"Bucholz EM, Whitlock RP, Zappitelli M, Devarajan P, Eikelboom J, Garg AX, Philbrook HT, Devereaux PJ, Krawczeski CD, Kavsak P, Shorttk C, Parikh CR. Cardiac biomarkers and acute kidney injury after cardiac surgery. Pediatrics. 2015;135. https:\/\/doi.org\/10.1542\/peds.2014-2949.","DOI":"10.1542\/peds.2014-2949"},{"key":"4926_CR71","doi-asserted-by":"crossref","unstructured":"Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart. 2006;92.","DOI":"10.1136\/hrt.2005.071282"},{"key":"4926_CR72","doi-asserted-by":"crossref","unstructured":"Tanindi A, Cemri M. Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag. 2011;7.","DOI":"10.2147\/VHRM.S24509"},{"key":"4926_CR73","unstructured":"Zbierska-Rubinkiewicz K, Tr\u0119bacz O, Tomala M, Rubinkiewicz M, Chrzan I, Gackowski A. Creatine kinase-MB and red cell distribution width as predictors of contrast-induced nephropathy after percutaneous coronary intervention in acute myocardial infarction. Folia Med Cracov. 2017;57."},{"key":"4926_CR74","doi-asserted-by":"publisher","unstructured":"Zahler D, Rozenfeld KL, Merdler I, Itach T, Morgan S, Levit D, Banai S, Shacham Y. Relation between Serum Creatine Phosphokinase Levels and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients. J Clin Med. 2022;11. https:\/\/doi.org\/10.3390\/jcm11041137.","DOI":"10.3390\/jcm11041137"},{"key":"4926_CR75","doi-asserted-by":"publisher","unstructured":"Alkassas A, Elbarbary Y, Sherif MH, El-Saied SB, Hagag RY, Elbarbary M. Biomarker array for prediction of acute kidney injury after percutaneous coronary intervention for patients who had acute ST segment elevation myocardial infarction. Heart Vessels. 2024;39. https:\/\/doi.org\/10.1007\/s00380-023-02330-0.","DOI":"10.1007\/s00380-023-02330-0"},{"key":"4926_CR76","doi-asserted-by":"crossref","unstructured":"Stephens JW, Brown KE, Min T. Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk. Diabetes Obes Metab. 2020;22.","DOI":"10.1111\/dom.13942"},{"key":"4926_CR77","doi-asserted-by":"publisher","unstructured":"Xu Y, Surapaneni A, Alkas J, Evans M, Shin JI, Selvin E, Chang A, Grams ME, Carrero JJ. Glycemic control and the risk of acute kidney injury in patients with type 2 diabetes and chronic kidney disease: Parallel population-based cohort studies in U.S. and Swedish routine care. Diabetes Care. 2020;43. https:\/\/doi.org\/10.2337\/dc20-1588.","DOI":"10.2337\/dc20-1588"},{"key":"4926_CR78","doi-asserted-by":"publisher","unstructured":"Peng J, Li X, Zhang D, Chen JK, Su Y, Smith SB, Dong Z. Hyperglycemia, p53, and mitochondrial pathway of apoptosis are involved in The susceptibility of diabetic models to ischemic acute kidney injury. Kidney Int. 2015;87. https:\/\/doi.org\/10.1038\/ki.2014.226.","DOI":"10.1038\/ki.2014.226"},{"key":"4926_CR79","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/J.JCRC.2017.03.029","volume":"40","author":"SM Elmedany","year":"2017","unstructured":"Elmedany SM, Naga SS, Elsharkawy R, Mahrous RS, Elnaggar AI. Novel urinary biomarkers and the early detection of acute kidney injury after open cardiac surgeries. J Crit Care. 2017;40:171\u20137. https:\/\/doi.org\/10.1016\/J.JCRC.2017.03.029.","journal-title":"J Crit Care"},{"key":"4926_CR80","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2215\/CJN.04010907","volume":"3","author":"M Bennett","year":"2008","unstructured":"Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, Syed H, Ali S, Barasch J, Devarajan P. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: A prospective study. Clin J Am Soc Nephrol. 2008;3:665\u201373. https:\/\/doi.org\/10.2215\/CJN.04010907.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4926_CR81","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","volume":"365","author":"J Mishra","year":"2005","unstructured":"Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(05)74811-X.","journal-title":"Lancet"},{"key":"4926_CR82","doi-asserted-by":"publisher","first-page":"712695","DOI":"10.1155\/2012\/712695","volume":"2012","author":"AA Royakkers","year":"2012","unstructured":"Royakkers AA, Bouman CS, Stassen PM, Korevaar JC, Binnekade JM, Van De Hoek W, Kuiper MA, Spronk PE, Schultz MJ. Systemic and Urinary Neutrophil Gelatinase-Associated Lipocalins Are Poor Predictors of Acute Kidney Injury in Unselected Critically Ill Patients. Crit Care Res Pract. 2012;2012:712695. https:\/\/doi.org\/10.1155\/2012\/712695.","journal-title":"Crit Care Res Pract"},{"key":"4926_CR83","doi-asserted-by":"publisher","first-page":"6265307","DOI":"10.1155\/2019\/6265307","volume":"2019","author":"NA Khreba","year":"2019","unstructured":"Khreba NA, Abdelsalam M, Wahab AM, Sanad M, Elhelaly R, Adel M, El-Kannishy G. Kidney Injury Molecule 1 (KIM-1) as an Early Predictor for Acute Kidney Injury in Post-Cardiopulmonary Bypass (CPB) in Open Heart Surgery Patients. Int J Nephrol. 2019;2019:6265307. https:\/\/doi.org\/10.1155\/2019\/6265307.","journal-title":"Int J Nephrol"},{"key":"4926_CR84","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2174\/187152811796117735\/CITE\/REFWORKS","volume":"10","author":"Y Huang","year":"2011","unstructured":"Huang Y, Don-Wauchope AC. The clinical utility of kidney injury molecule 1 in the prediction, diagnosis and prognosis of acute kidney injury: A systematic review. Inflamm Allergy - Drug Targets. 2011;10:260\u201371. https:\/\/doi.org\/10.2174\/187152811796117735\/CITE\/REFWORKS.","journal-title":"Inflamm Allergy - Drug Targets"},{"key":"4926_CR85","doi-asserted-by":"publisher","unstructured":"Bae J, Yang SH, Kim A, Kim HG. RNA-based biomarkers for the diagnosis, prognosis, and therapeutic response monitoring of prostate cancer. Urol Oncol Semin Orig Investig. 2022;40:105.e1-105.e10. https:\/\/doi.org\/10.1016\/J.UROLONC.2021.11.012.","DOI":"10.1016\/J.UROLONC.2021.11.012"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04926-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04926-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04926-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:58:46Z","timestamp":1781647126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04926-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4926"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04926-w","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and received ethical approval from the Ain Shams University Faculty of Medicine Ethics Committee (FWA 000017585).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants prior to enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}